Sponsor or institution
Clinical trials and research at Geneventiv Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $1.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Creating a universal gene therapy for hemophilia A and B
This study is testing a new gene therapy for people with hemophilia A and B to help their bodies make the clotting factors they need, aiming to provide a longer-lasting solution than the usual treatments, and it’s designed for both patients who have developed antibodies against these treatments and those who haven’t.
-
Creating a universal gene therapy for hemophilia A and B
This study is testing a new gene therapy that could help people with hemophilia A and B by providing a long-lasting treatment, so they won’t need to get regular infusions of clotting factors anymore, especially for those who have trouble with traditional treatments.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.